EUCTR2006-002950-32-DK进行中（未招募）1 期
ong term effects of DPP-IV inhibitor treatment on the secretion and action of the incretin hormones in patients with type 2 diabetes
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Type 2 diabetes diagnosed according to and in accordance with the WHO criteria
- •Metformin treatment of = 1 gram
- •7,0 % = HbA1c = 10%
- •BMI = 25 kg/m2
- •Informed consent
- •Contraception, if appropriate
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Proliferating retinopathy
- •Uremia, end stage renal disease, diabetic nephropathy or any other cause of impaired renal function with s-creatinine > 130 µM and/or albuminuria (>300 mg/day)
- •Liver disease with ALAT and/or ASAT > 2 x normal value
- •Complicated coronary artery disease, NYHA group III and IV
- •Positive screening for islet cell auto antibodies and/or GAD-65 auto antibodies
- •Occurrence of type 1 diabetes in first degree relatives
- •Pregnancy and/or breast feeding
- •Treatment with medication affecting insulin secretion
- •non-compliance
研究者
相似试验
已完成
不适用
The Effects of 6-Month DPP-4 inhibitor Treatment in Diabetic Patients during Oral Glucocorticoids AdministratioDiabetesJPRN-UMIN000014508ational Center for Global Health and Medicine, Kohnodai Hospital50
已完成
不适用
ong-term efficacy and safety of the DPP-4 inhibitors in Japanese patients with type 2 diabetes mellitus.Type 2 Diabetes mellitusJPRN-UMIN000038801akakinen clinic3,000
已完成
4 期
A study on efficacy and safety of a DPP-IV inhibitor in type 2 diabetes patientsDiabetesJPRN-UMIN000003057Saga lifestyle related disease treatment study group secretariat300
已完成
不适用
Clinical study examining effect of DPP-4 inhibitors on postprandial hyperlipidemiaType 2 diabetes mellitusJPRN-UMIN000010177Shimane University Faculty of Medicine30
已完成
不适用
Efficacy and safety of DPP-4 inhibitor added to insulin for treatment of type 2 diabetesType 2 diabetesJPRN-UMIN000004678Keio University , School of Mecidicine, Department of Internal Medicine50